University of North Carolina


UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®): Top Experts in Coronaviruses

Remdesivir has become a blockbuster drug in short time thanks in part to a pandemic-driven ACTIV-1 clinical trial and subsequent U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) in May followed by permanent approval on October 22. Any...

Innovative UNC-based Public-Private HIV Investigative Group Secures $20m & Continues its Leading ‘Induce & Reduce’ Strategy

University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique,...

Pin It on Pinterest